| 产品名称： | 44aacb |
|---|---|
| 商品货号： | TS212860 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Applications： | The antibody reacts with human CD11b, and blocks a variety of CD11b/CD18 mediated activities including neutrophil - substrate adherence and C3bi rosette formation on neutrophils, monocytes, macrophages and some NK cells. The antibody cross-reacts with CD11b from non-human primates. |
| Derivation： | Spleen cells were fused with NS-1 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human CD11b |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human CD11b |
| Comments： | Animals were immunized with human acute monocytic leukemia cells (FAM M6). Spleen cells were fused with NS-1 myeloma cells. The antibody reacts with human CD11b, and blocks a variety of CD11b/CD18 mediated activities including neutrophil - substrate adherence and C3bi rosette formation on neutrophils, monocytes, macrophages and some NK cells. The antibody cross-reacts with CD11b from non-human primates. |
| Complete Growth Medium： | The base medium for this cell line is ATCC Hybri-Care Medium, Catalog No. 46-X. Hybri-Care Medium is supplied as a powder and should be reconstituted in 1 L cell-culture-grade water. To make the complete growth medium, add the following components to the base medium:
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG2a; kappa light chain |
| Name of Depositor： | RF Todd |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Arnaout MA, et al. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte- granulocyte membrane glycoprotein (Mol). J. Clin. Invest. 72: 171-179, 1983. PubMed: 6874946 Simon RH, et al. Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J. Clin. Invest. 78: 1375-1386, 1986. PubMed: 3771800 Ismail G, et al. Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mo1 monoclonal antibody. Blood 69: 1167-1174, 1987. PubMed: 3030466 Dana N, et al. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J. Immunol. 137: 3259-3263, 1986. PubMed: 2430017 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 44aacb |
|---|---|
| 商品货号： | TS212860 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Applications： | The antibody reacts with human CD11b, and blocks a variety of CD11b/CD18 mediated activities including neutrophil - substrate adherence and C3bi rosette formation on neutrophils, monocytes, macrophages and some NK cells. The antibody cross-reacts with CD11b from non-human primates. |
| Derivation： | Spleen cells were fused with NS-1 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human CD11b |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human CD11b |
| Comments： | Animals were immunized with human acute monocytic leukemia cells (FAM M6). Spleen cells were fused with NS-1 myeloma cells. The antibody reacts with human CD11b, and blocks a variety of CD11b/CD18 mediated activities including neutrophil - substrate adherence and C3bi rosette formation on neutrophils, monocytes, macrophages and some NK cells. The antibody cross-reacts with CD11b from non-human primates. |
| Complete Growth Medium： | The base medium for this cell line is ATCC Hybri-Care Medium, Catalog No. 46-X. Hybri-Care Medium is supplied as a powder and should be reconstituted in 1 L cell-culture-grade water. To make the complete growth medium, add the following components to the base medium:
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG2a; kappa light chain |
| Name of Depositor： | RF Todd |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Arnaout MA, et al. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte- granulocyte membrane glycoprotein (Mol). J. Clin. Invest. 72: 171-179, 1983. PubMed: 6874946 Simon RH, et al. Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J. Clin. Invest. 78: 1375-1386, 1986. PubMed: 3771800 Ismail G, et al. Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mo1 monoclonal antibody. Blood 69: 1167-1174, 1987. PubMed: 3030466 Dana N, et al. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J. Immunol. 137: 3259-3263, 1986. PubMed: 2430017 |
